131 related articles for article (PubMed ID: 32372739)
41. Risk of appendicitis associated with the use of clozapine: A pharmacovigilance study.
Uwai Y; Nabekura T
Asian J Psychiatr; 2022 Nov; 77():103264. PubMed ID: 36150349
[No Abstract] [Full Text] [Related]
42. Treatment decisions for elderly patients with haematological malignancies: a dilemma.
Peyrade F; Gastaud L; Ré D; Pacquelet-Cheli S; Thyss A
Lancet Oncol; 2012 Aug; 13(8):e344-52. PubMed ID: 22846839
[TBL] [Abstract][Full Text] [Related]
43. Major histocompatibility complex associations with clozapine-induced agranulocytosis. The USA experience.
Yunis JJ; Lieberman J; Yunis EJ
Drug Saf; 1992; 7 Suppl 1():7-9. PubMed ID: 1503679
[TBL] [Abstract][Full Text] [Related]
44. Association between diabetes and haematological malignancies: a population-based study.
Gong IY; Cheung MC; Read S; Na Y; Lega IC; Lipscombe LL
Diabetologia; 2021 Mar; 64(3):540-551. PubMed ID: 33409570
[TBL] [Abstract][Full Text] [Related]
45. Pharmacovigilance approaches to study rare and very rare side-effects: the example of clozapine-related DiHS/DRESS syndrome.
de Filippis R; De Fazio P; Kane JM; Schoretsanitis G
Expert Opin Drug Saf; 2022 May; 21(5):585-587. PubMed ID: 35417282
[No Abstract] [Full Text] [Related]
46. Oral fish oil positively influences nutritional-inflammatory risk in patients with haematological malignancies during chemotherapy with an impact on long-term survival: a randomised clinical trial.
Chagas TR; Borges DS; de Oliveira PF; Mocellin MC; Barbosa AM; Camargo CQ; Del Moral JÂG; Poli A; Calder PC; Trindade EBSM; Nunes EA
J Hum Nutr Diet; 2017 Dec; 30(6):681-692. PubMed ID: 28374923
[TBL] [Abstract][Full Text] [Related]
47. A Working Hypothesis Regarding Identical Pathomechanisms between Clinical Efficacy and Adverse Reaction of Clozapine via the Activation of Connexin43.
Okada M; Fukuyama K; Shiroyama T; Murata M
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987640
[TBL] [Abstract][Full Text] [Related]
48. The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study.
von Felden J; Alric L; Pischke S; Aitken C; Schlabe S; Spengler U; Giordani MT; Schnitzler P; Bettinger D; Thimme R; Xhaard A; Binder M; Ayuk F; Lohse AW; Cornelissen JJ; de Man RA; Mallet V
J Hepatol; 2019 Sep; 71(3):465-472. PubMed ID: 31108159
[TBL] [Abstract][Full Text] [Related]
49. Antiblastic treatment of haematological malignancies during pregnancy: a crucial decision.
Michieli M; Peccatori FA; Lleshi A; Del Pup L; Valente D; Rupolo M; Tirelli U; Berretta M
Int J Immunopathol Pharmacol; 2012; 25(2 Suppl):21S-32S. PubMed ID: 23092517
[TBL] [Abstract][Full Text] [Related]
50. Density of Demodex folliculorum in haematological malignancies.
Seyhan ME; Karincaoğlu Y; Bayram N; Aycan O; Kuku I
J Int Med Res; 2004; 32(4):411-5. PubMed ID: 15303773
[TBL] [Abstract][Full Text] [Related]
51. Clozapine-induced blood dyscrasias in Saudi Arab patients.
Abanmy NO; Al-Jaloud A; Al-Jabr A; Al-Ruwaisan R; Al-Saeed W; Fatani S
Int J Clin Pharm; 2014 Aug; 36(4):815-20. PubMed ID: 24917217
[TBL] [Abstract][Full Text] [Related]
52. Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy.
Takai S; Tsurumi H; Ando K; Kasahara S; Sawada M; Yamada T; Hara T; Fukuno K; Takahashi T; Oyama M; Onishi H; Tomita E; Takami T; Imawari M; Moriwaki H
Eur J Haematol; 2005 Feb; 74(2):158-65. PubMed ID: 15654908
[TBL] [Abstract][Full Text] [Related]
53. Aerobic physical exercise for adult patients with haematological malignancies.
Knips L; Bergenthal N; Streckmann F; Monsef I; Elter T; Skoetz N
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009075. PubMed ID: 30702150
[TBL] [Abstract][Full Text] [Related]
54. Antimicrobial utilization and antimicrobial resistance in patients with haematological malignancies in Japan: a multi-centre cross-sectional study.
Mimura W; Fukuda H; Akazawa M
Ann Clin Microbiol Antimicrob; 2020 Feb; 19(1):7. PubMed ID: 32066448
[TBL] [Abstract][Full Text] [Related]
55. [Clozapine and agranulocitosis in Spain: do we have a safer population? A 5-year hematologic follow-up].
Pons A; Undurraga J; Batalla A; Bernardo M
Rev Psiquiatr Salud Ment; 2012; 5(1):37-42. PubMed ID: 22854502
[TBL] [Abstract][Full Text] [Related]
56. Targeted therapy for haematological malignancies: clinical update from the American Society of Hematology, 2004.
Haas M; Lonial S
Expert Opin Investig Drugs; 2005 Sep; 14(9):1161-9. PubMed ID: 16144500
[TBL] [Abstract][Full Text] [Related]
57. Hospital end-of-life care in haematological malignancies.
Beaussant Y; Daguindau E; Chauchet A; Rochigneux P; Tournigand C; Aubry R; Morin L
BMJ Support Palliat Care; 2018 Sep; 8(3):314-324. PubMed ID: 29434048
[TBL] [Abstract][Full Text] [Related]
58. Clozapine-induced late leukopenia.
Latif Z; Malik MA; Jabbar F; Ahmed Y; McDonough C
Ir J Med Sci; 2012 Mar; 181(1):139-41. PubMed ID: 20872253
[TBL] [Abstract][Full Text] [Related]
59. Real world analysis of cardiac adverse events associated with clozapine: A pharmacovigilance analysis using food and drug administration adverse event reporting system.
Thotamgari SR; Bath AS; Dhaliwal L; Kommineni SK; Aujla P; Brar V
Gen Hosp Psychiatry; 2022; 78():123-125. PubMed ID: 35396035
[No Abstract] [Full Text] [Related]
60. A comprehensive approach to therapy of haematological malignancies in older patients.
Cordoba R; Eyre TA; Klepin HD; Wildes TM; Goede V
Lancet Haematol; 2021 Nov; 8(11):e840-e852. PubMed ID: 34624238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
